Tissue inhibitors of metalloproteinases: evolution, structure and function.
暂无分享,去创建一个
[1] R. Williamson,et al. The Specificity of TIMP-2 for Matrix Metalloproteinases Can Be Modified by Single Amino Acid Mutations* , 1999, The Journal of Biological Chemistry.
[2] Robert Blelloch,et al. Control of organ shape by a secreted metalloprotease in the nematode Caenorhabditis elegans , 1999, Nature.
[3] H. Erdjument-Bromage,et al. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. , 1999, The Journal of clinical investigation.
[4] T. Godenschwege,et al. Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human. , 1999, Genomics.
[5] U. Thorgeirsson,et al. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. , 1999, Biochemical and biophysical research communications.
[6] K. Brew,et al. Residue 2 of TIMP-1 Is a Major Determinant of Affinity and Specificity for Matrix Metalloproteinases but Effects of Substitutions Do Not Correlate with Those of the Corresponding P1′ Residue of Substrate* , 1999, The Journal of Biological Chemistry.
[7] A. Baker,et al. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 , 1999, British Journal of Cancer.
[8] G. Schneider,et al. Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution. , 1998, Journal of molecular biology.
[9] Y. Itoh,et al. Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface* , 1998, The Journal of Biological Chemistry.
[10] P. Slocombe,et al. TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .
[11] J. Calvete,et al. Crystal structure of the complex formed by the membrane type 1‐matrix metalloproteinase with the tissue inhibitor of metalloproteinases‐2, the soluble progelatinase A receptor , 1998, The EMBO journal.
[12] H. Nagase. Cell surface activation of progelatinase A (proMMP-2) and cell migration , 1998, Cell Research.
[13] R. Williamson,et al. High Resolution Structure of the N-terminal Domain of Tissue Inhibitor of Metalloproteinases-2 and Characterization of Its Interaction Site with Matrix Metalloproteinase-3* , 1998, The Journal of Biological Chemistry.
[14] M. Stetler-Stevenson,et al. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. , 1998, Blood.
[15] N. Ohba,et al. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby’s fundus dystrophy with unusual clinical features , 1998, Human Genetics.
[16] K. Brocklehurst,et al. Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: evidence for the existence of a low-affinity intermediate. , 1998, Biochemistry.
[17] M. Barker,et al. Localization of the Functional Domains of Human Tissue Inhibitor of Metalloproteinases-3 and the Effects of a Sorsby’s Fundus Dystrophy Mutation* , 1998, The Journal of Biological Chemistry.
[18] Y. Okada,et al. TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.
[19] T. Hoshino,et al. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. , 1998, Journal of cell science.
[20] A. Baker,et al. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.
[21] M. Cilli,et al. TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis , 1998 .
[22] Gillian Murphy,et al. The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.
[23] V. Kähäri,et al. High level expression of tissue inhibitors of metalloproteinases-1,-2 and -3 in melanoma cells achieved by adenovirus mediated gene transfer. , 1998, Advances in experimental medicine and biology.
[24] K. Taylor,et al. Replacement of Conserved Cysteines in Human Tissue Inhibitor of Metalloproteinases-1* , 1997, The Journal of Biological Chemistry.
[25] R. Fridman,et al. Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2* , 1997, The Journal of Biological Chemistry.
[26] R. Williamson,et al. Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. , 1997, Biochemistry.
[27] N. Colburn,et al. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. , 1997, Cytokine.
[28] D. Gomez,et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.
[29] R. Huber,et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 , 1997, Nature.
[30] K. Brew,et al. Mutational Study of the Amino-terminal Domain of Human Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Locates an Inhibitory Region for Matrix Metalloproteinases* , 1997, The Journal of Biological Chemistry.
[31] S. Sheng,et al. Preparation and Characterization of Recombinant Tissue Inhibitor of Metalloproteinase 4 (TIMP-4)* , 1997, The Journal of Biological Chemistry.
[32] K. Suzuki,et al. Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). , 1997, The Biochemical journal.
[33] C. Overall,et al. Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase A , 1997, The Journal of Biological Chemistry.
[34] P. Soloway,et al. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene. , 1997, Biology of reproduction.
[35] H. Nagase. Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.
[36] G. Murphy,et al. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? , 1997, Matrix biology : journal of the International Society for Matrix Biology.
[37] G. Butler,et al. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. , 1997, European journal of biochemistry.
[38] S. Dey,et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. , 1997, Developmental genetics.
[39] R. Williamson,et al. Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies. , 1996, European journal of biochemistry.
[40] K. Taylor,et al. The Mechanism of Inhibition of Collagenase by TIMP-1* , 1996, The Journal of Biological Chemistry.
[41] N. Colburn,et al. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. , 1996, Carcinogenesis.
[42] G. Butler,et al. The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.
[43] K. Brew,et al. Folding and characterization of the amino‐terminal domain of human tissue inhibitor of metalloproteinases‐1 (TIMP‐1) expressed at high yield in E. coli , 1996, FEBS letters.
[44] M. Lim,et al. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[45] C. López-Otín,et al. Biochemical Characterization of Human Collagenase-3 (*) , 1996, The Journal of Biological Chemistry.
[46] N. Bersch,et al. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. , 1995, Blood.
[47] Hiroshi Sato,et al. Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library , 1995, The Journal of Biological Chemistry.
[48] V. Papadopoulos,et al. Identification of a stimulator of steroid hormone synthesis isolated from testis. , 1995, Science.
[49] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[50] G Murphy,et al. Tissue inhibitors of matrix metalloendopeptidases. , 1995, Methods in enzymology.
[51] R. Williamson,et al. Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. , 1994, Biochemistry.
[52] A. Shinagawa,et al. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1994, Journal of cell science.
[53] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[54] W. Stetler-Stevenson,et al. Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferation , 1993, Journal of cellular physiology.
[55] P. Slocombe,et al. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. , 1993, Biochemistry.
[56] A. Murzin. OB(oligonucleotide/oligosaccharide binding)‐fold: common structural and functional solution for non‐homologous sequences. , 1993, The EMBO journal.
[57] S. Hawkes,et al. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[58] N. Pavloff,et al. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. , 1992, The Journal of biological chemistry.
[59] A. Strongin,et al. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.
[60] K. Iwata,et al. Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.
[61] W. Stetler-Stevenson,et al. Tissue inhibitor of metalloproteinase‐2 (TIMP‐2) has erythroid‐potentiating activity , 1992, FEBS letters.
[62] A. Eisen,et al. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. , 1991, The Journal of investigative dermatology.
[63] R. Williamson,et al. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. , 1991, Biochemistry.
[64] C. Overall,et al. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. , 1990, The Journal of biological chemistry.
[65] H. Morris,et al. Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). , 1990, The Biochemical journal.
[66] P. Stephens,et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.
[67] E. Brown,et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity , 1985, Nature.
[68] B. Hazleman,et al. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. , 1983, The Biochemical journal.